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This review aims to contribute to the growing knowledge on bioactive (antioxidant, 
antitumor and antimicrobial) properties of polysaccharides, glycoproteins and 
polysaccharidic extracts obtained from Ganoderma species. The chemical features were 
analyzed and related to correspondent bioactivities. 
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Research highlights  
Chemical features of Ganoderma bioactive polysaccharides were discussed. 
Methods for extraction, isolation and identification were evaluated. 
Bioactivity of polysaccharidic extracts and purified compounds were discussed.  
Integration of data allowed deduction of structure-activity relationships. 
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ABSTRACT 
Ganoderma genus comprises one of the most commonly studied species worldwide, G. 
lucidum. However, other Ganoderma species have been also reported as important 
sources of bioactive compounds. Polysaccharides are important contributors to the 
medicinal properties reported for Ganoderma species, as demonstrated by the numerous 
publications, including reviews, on this matter. Yet, what are the chemical features of 
Ganoderma polysaccharides that have bioactivity? In the present manuscript, the 
chemical features of Ganoderma polysaccharides with reported antioxidant, antitumor 
and antimicrobial activities (the most studied worldwide) are analyzed in detail. The 
composition of sugars (homo- versus hetero-glucans and other polysaccharides), type of 
glycosidic linkages, branching patterns, and linkage to proteins are discussed. Methods 
for extraction, isolation and identification are evaluated and, finally, the bioactivity of 
polysaccharidic extracts and purified compounds are discussed. The integration of data 
allows deduction of structure-activity relationships and gives clues to the chemical 
aspects involved in Ganoderma bioactivity.   
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1. Introduction 
Ganoderma is a genus of polypore macrofungi growing in decaying logs or tree stumps 
(Kirk et al., 2011). Commonly known as Lingzhi, Ganoderma comprises the most 
studied species of medicinal mushrooms in the world. In ancient China, Lingzhi was 
believed to bring longevity, due to its mysterious power of healing the body and 
calming the mind (Huie and Di, 2004). 
 
1.1. Bioactivity of Ganoderma 
The above mentioned genus has been widely studied regarding its  bioactive properties 
(Paterson, 2006; Nie et al., 2013), including antibacterial, antioxidant, antitumor and 
other effects (Wang et al., 1997; Wasser, 2002; Heleno et al., 2012; Li et al., 2012; 
Heleno et al., 2013; Popović et al., 2013; Zhonghui et al., 2013). The beneficial health 
properties of Ganoderma species are attributed to a wide variety of bioactive 
components, such as polysaccharides, triterpenes, sterols, lectins and other proteins 
(Wang et al., 2002; Ferreira et al., 2010).  
Different kinds of bioactive polysaccharides have been extracted and isolated from the 
fruiting bodies of different Ganoderma species (Kozarsky et al., 2011; Liu et al., 2010; 
Kozarsky et al., 2012; Ma et al., 2013; Shi et al., 2013), and represent a structurally 
diverse class of biological macromolecules with a wide-range of physiological 
properties.  The major bioactive Ganoderma polysaccharides are composed of (1→3), 
(1→6)-α/β-glucans, glycoproteins and water soluble heteropolysaccharides (Nie et al., 
2013) with glucose, mannose, galactose, fucose, xylose and arabinose combined in 
different proportions and types of glycosidic linkages, as well as peptide bonds (Chen et 
al., 2008; Wang and Zhang, 2009). As polysaccharides are very complex molecules, 
their detailed characterization in specific glycosidic linkages, molecular weight and 
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sugars composition is mandatory in order to establish structure-biological activity 
relationships. Nevertheless most of the articles available in the literature, do not report 
these parameters, which is a drawback in the understanding of the most crucial chemical 
features for polysaccharides bioactive properties such as antioxidant, antitumor and 
antimicrobial activities. 
 
1.2. Bioactivity of Ganoderma polysaccharides 
Most of the studies on bioactivities of polysaccharides, glycopeptides or polysaccharidic 
crude extracts have been performed using Ganoderma lucidum (Nie et al., 2013). This 
species has been under special attention because of the potent antioxidant, antitumor 
and antibacterial activities of the polysaccharides, glycoproteins and polysaccharidic 
extracts obtained from the fruiting bodies (Jia et al., 2009; XiaoPing et al., 2009; Shi et 
al., 2013).  
Antioxidant properties include free radicals scavenging abilities, reducing power and 
chelating effects on ferrous ions, among others (Liu et al., 2010; Kozarski et al., 2011). 
The radicals scavenging activity seems to be related to an increase in the activity of 
antioxidant enzymes: superoxide dismutase (SOD) which catalyzes dismutation of 
superoxide anion to hydrogen peroxide; catalase (CAT) which detoxifies hydrogen 
peroxide and converts lipid hydroperoxides to nontoxic substances; and glutathione 
peroxidase (GSH-Px) which maintains the levels of reduced glutathione (GSH) 
(YouGuo et al., 2009; XiaoPing et al., 2009).  
Antitumor polysaccharides exert their bioactivity mostly via activation of the immune 
response of the host, enhancing the host’s defense system (Mizuno et al., 1995b). The 
antitumor properties of water-soluble polysaccharide-enriched fractions from the 
fruiting bodies of G. lucidum seem to be related to the production stimulation of 
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interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 from human monocyte-
macrophages, and interferon (IFN)-γ from T lymphocytes (Wang et al., 1997). 
There are only a few reports on antimicrobial activities of polysaccharides from 
Ganoderma species. This genus has been widely studied for its therapeutic properties, 
but less investigated as a source of new antibacterial agents (Gao et al., 2003a). 
Nevertheless, some polysaccharides from Ganoderma species exert antibacterial 
activity by inhibiting the growth of bacteria and, in some cases, by killing pathogenic 
bacteria (Skalicka-Woźniak et al., 2012).  
Although being very active as antioxidants and antimicrobials, Ganoderma 
polysaccharides are mostly known as antitumor agents; however the mechanisms of 
action involved in their bioactivities are not well understood. Furthermore, most of the 
studies are performed under in vitro conditions, with very few experiments using in vivo 
assays. 
This review aims to contribute to the knowledge of bioactivity (mainly antioxidant, 
antitumor and antimicrobial properties) of polysaccharides, glycoproteins and 
polysaccharidic extracts obtained from Ganoderma species. The most common 
extraction and isolation procedures are presented, including their chemical features. 
This includes discussion of monosaccharides’ composition, type of glycosidic linkages, 
branching patterns and linkages to proteins, with these features being related to the 
corresponding bioactivities. 
 
2. Extraction, isolation and identification of Ganoderma polysaccharides 
2.1. Chemical features of the most common polysaccharides found in Ganoderma 
According to different researchers, the polysaccharides isolated from Ganoderma are 
constituted by glucose, mannose, galactose, fucose, xylose and arabinose, with different 
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combinations and different types of glycosidic linkages, and which can be bound to 
protein or peptide residues (polysaccharide-protein or -peptide complexes) (Sone et al., 
1985; Zhang et al., 2007; Chen et al., 2008; Wang and Zhang, 2009; Ferreira et al., 
2010; Nie et al., 2013). These carbohydrates are characterized by their molecular 
weight, degree of branching, and higher (tertiary) structures (Ferreira et al., 2010), and 
have different compositions, comprising β-glucans, hetero-β-glucans, heteroglycans or 
α-manno-β-glucan complexes (Moradali et al., 2007).  
Homo-glucans are linear or branched biopolymers having a backbone composed of α- 
or β-linked glucose units (such as (1→3), (1→6)-β-glucans and (1→3)-α-glucans), and 
might contain side-chains attached at different positions. Among the homo-glucans, β-
glucans (primary components of the cell walls of higher fungi) are glucose polymers 
that can exist as a non-branched (1→3)-β-linked backbone or as a (1→3)-β-linked 
backbone with (1→6)-β-branches (Moradali et al., 2007; Ferreira et al., 2010).  
These polysaccharides have either linear or branched molecules in a backbone 
composed of α- or β-linked glucose units, containing side-chains that are attached in 
different ways. Hetero-glucan side-chains contain glucuronic acid, xylose, galactose, 
mannose, arabinose or ribose moieties as a main component or in different 
combinations (Wasser, 2002; Ferreira et al., 2010). 
Glycans are other polysaccharides that are found in Ganoderma. These polysaccharides, 
in general, contain units other than glucose in their backbone. They are classified as 
galactans, fucans, xylans, and mannans by the individual sugar components in the 
backbone (Moradali et al., 2007). Hetero-glycan side-chains contain arabinose, 
mannose, fucose, galactose, xylose, glucuronic acid, and glucose as a main component 
or in different combinations (Wasser, 2002; Moradali et al., 2007). 
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Polysaccharides can also be covalently bound to proteins or peptides as polysaccharide-
protein or –peptide complexes, which possess antioxidant and antitumor potential (Jia et 
al., 2009; Ferreira et al., 2010). Glycoproteins are polysaccharide-protein complexes, 
and such compounds include β-glucan-protein, α-glucan-protein and heteroglycan-
protein complexes. On the other hand, glycopeptides are a group structurally similar to 
glycoproteins, but with a smaller chain of amino acids (Ferreira et al., 2010). Finally, 
proteoglycans are another class of glycoproteins, which are heavily glycosylated. They 
consist of a core protein with one or more covalently attached glycosaminoglycan 
chain(s) (Moradali et al., 2007). An example of this is GLIS (G. lucidum 
immunomodulating substance), a bioactive proteoglycan isolated from the fruiting 
bodies of G. lucidum.  GLIS contains carbohydrates and proteins in a ratio of 11.5:1, 
being the carbohydrate portion formed by seven different monosaccharides, 
predominantly D-glucose, D-galactose, and D-mannose in a molar ratio of 3:1:1 (Zhang 
et al., 2002). Thus, polysaccharides have been under special attention since they have an 
utmost capacity for carrying biological information because they have great potential 
for structural variability (Wasser, 2002).  
Polysaccharides have a huge diversity in their chemical structure and composition, and 
several details can differently influence their specific bioactivities. Thus, the full 
characterization of these molecules is crucial in order to identify the main bioactive 
groups and study the respective mechanism of action. 
 
2.2. Extraction procedures 
A wide range of polysaccharides with different chemical structures has been extracted 
and isolated from Ganoderma species with demonstrated bioactive properties such as 
antioxidant (Table 1), antitumor (Table 2) and antimicrobial (Table 3) activities.  
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According to the polysaccharide characteristics, the selection of an extraction method is 
very important; it is based on the structure and water-solubility of the polysaccharide, 
and depends especially on the cell wall structure. The basic principle is to break the cell 
wall from the outer layer to the inner layer under mild-to-strong extraction conditions 
(pH and temperature) (Zhang et al., 2007). Based on this principle, most 
polysaccharides are extractable with hot water, or acidic, saline and dilute alkali 
solutions, or with dimethyl sulfoxide (Mizuno et al., 1995a; Wasser and Weis, 1999; 
Gao et al., 2004; Zhao et al., 2005; Ye et al., 2009; YouGuo et al., 2009; Liu et al., 
2010; Dong et al., 2012; Nie et al., 2013; Zhonghui et al., 2013). 
Hot water extraction is the most common methodology for extraction of 
polysaccharides from Ganoderma. High temperature is required to accelerate 
dissolution of polysaccharides from cell walls (Nie et al., 2013). Hence, traditional 
procedures for extraction begin with powders of raw materials being defatted by organic 
solvents or with 80% aqueous ethanol to eliminate low molecular weight compounds. 
After that, the material is successively extracted with water (e.g., 100ºC for 3 h), or with 
saline and diluted alkali solutions at different temperatures (e.g., 2% ammonium oxalate 
at 100ºC for 6 h, and 5% sodium hydroxide at 80ºC for 6 h). The hot water extraction 
yields water-soluble polysaccharides; on the other hand, extraction with alkali solution 
yields water-insoluble ones (Zhang et al., 2007; Nie et al, 2013). 
Other techniques such as microwave, ultrasonic, ultrasonic/microwave, and enzymatic 
treatments are also used, which could promote the breakage of the cell wall and increase 
the yield of the extracted polysaccharides (Huang et al., 2007; Xu et al., 2007; Huang 
and Ning, 2010; Zhao et al., 2010; Huang et al., 2011; Ma et al., 2013; Shi et al., 2013). 
However, following the extraction procedure itself, it is necessary to remove free 
proteins. Sevag method is the typically used method for this in Ganoderma species (the 
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proteins are precipitated after repeated denaturation by shaking with a solution of 
octanol in chloroform) (Staub, 1999). 
In order to obtain the crude polysaccharides after dialyzing against water, the de-
proteinized solution is precipitated by alcohol, methanol or acetone. Finally, to obtain 
pure polysaccharides, purification is usually carried out through chromatographic 
techniques, such as ion-exchange, gel filtration and affinity chromatography (Zhang et 
al., 2007; Chen et al., 2008; Huang et al., 2011; Jiang et al., 2012). Essentially, ion-
exchange chromatography through DEAE-cellulose columns separate neutral 
polysaccharides from acidic ones. Neutral polysaccharides are then separated into α-
glucans (adsorbed fraction) and β-glucans (non-adsorbed fraction) using gel filtration 
and affinity chromatography. The same procedure with acidic polysaccharides (after 
elution with 1 M NaCl) yields purified polysaccharides (Mizuno, 1999). A combination 
of techniques may also be used, such as fractionation by ethanol, fractional 
precipitation, acidic precipitation with acetic acid or freeze-thawing (Liang et al., 1994; 
Zhang et al., 2007).  
As mentioned above, the extraction procedures/conditions are applied according to the 
characteristics (e.g., molecular weight, solubility) of the target polysaccharide(s). Most 
of the extraction procedures are well established and have been optimized in order to 
increase the extraction yield and efficiency by the use of new techniques such as 
ultrasonic/microwave and enzymatic treatments. 
 
2.3. Isolation and identification procedures 
Since glycan structures are diversified, it becomes difficult to define a universal 
protocol for their analysis. The primary structure of a polysaccharide is defined by the 
composition in monosaccharides, configuration and position of glycosidic linkages, 
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sequence of monosaccharides, as well as the nature, number and location of appended 
non-carbohydrate groups. The analytical methods used to determine the primary 
structures of polysaccharides include gas-liquid chromatography with flame ionization 
detection (GLC-FID), gas-liquid chromatography with mass spectrometry (GLC-MS) 
and high performance liquid chromatography (HPLC), techniques that allow evaluation 
of monosaccharides’ composition; high performance anion-exe chromatography with 
pulsed amperometric detection (HPAEC-PAD), infrared (IR), exoglycosidase digestion 
with specific enzymes (limited to a few enzymes of high specificity) and mass 
spectrometry (MS) for the analysis of the configuration (α, β) of the anomeric carbon 
and position of the glycosidic linkages; and nuclear magnetic resonance (NMR) 
spectroscopic analysis that, besides the two previous features, allows inference of the 
sequence of the polysaccharide(s) (Varki et al., 1999; Zhao et al., 2005; Zhang et al., 
2007; Ye et al., 2009; Dong et al., 2012; Shi et al., 2013). Monosaccharide’s analysis 
provides precise molar ratios of individual sugars, and may suggest the presence of 
specific oligosaccharide classes, such as N- or O-glycans (Zhang et al., 2007). 
These techniques also allow obtaining the molecular weight of the polysaccharides. 
Sone et al. (1985) used HPLC to obtain the molecular weight of the polysaccharides 
from fruiting bodies and cultured medium of G. lucidum. In addition, Chen et al. (2008) 
obtained the molecular weight of a water-soluble protein-bound polysaccharide through 
gel chromatography. Moreover, Zhao et al. (2010) determined the homogeneity and 
average molecular weight of polysaccharide fractions by high performance gel filtration 
chromatography (HPGFC). More recently, Ma et al. (2013) determined the molecular 
weight distribution of G. lucidum polysaccharides (GLP) using high-performance gel 
permeation chromatography (HP-GPC) with an HPLC apparatus. 
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Other features, like conformational properties (e.g., polysaccharide dynamics), remain 
an area still under investigation. With development of high resolution instrumental 
processes, such as various light scattering techniques, x-ray diffraction analysis, small-
angle neutron scattering (SANS), atomic force microscopy (AFM) and high resolution 
NMR spectroscopy, it has become possible to study the conformation and 3D structure 
of a polysaccharide at the molecular level. Indeed, through the use of molecular 
mechanics and computer assisted energy minimization methods, it is possible to 
simulate and visualize the 3D structure of polysaccharides (Zhang et al., 2007). 
Currently, there are numerous existing tools for the isolation and characterization of 
polysaccharides.  
New isolation and identification techniques have been applied to polysaccharides 
analysis, facilitating the elucidation of their chemical structures. The use of efficient 
technologies such as NMR and MS, among others described above, allows the 
determination of specific chemical characteristics, such as the type of glycosidic 
linkages, sugars composition, and molecular weight. With this information it is possible 
to establish the main features on polysaccharides structure related to bioactivity, and 
give clues on this relationship. 
 
3. Antioxidant activity 
3.1. Ganoderma polysaccharides  
Among the Ganoderma genus, there are several reports in the literature describing the 
antioxidant activity of polysaccharides isolated from G. lucidum (Li et al., 2007; 
YouGuo et al., 2009; XiaoPing et al., 2009; Liu et al., 2010; Kao et al., 2012; Ma et al., 
2013; Shi et al., 2013; Zhonghui et al., 2013) (Table 1).  
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Homo-glucans and hetero-glucans isolated from this species have promising radical 
scavenging abilities, as evaluated by several in vitro antioxidant assays, such as 2,2-
diphenyl-1-picrylhydrazyl (DPPH) scavenging activity, reducing power, chelating 
ability, hydroxyl radical scavenging activity, 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid (ABTS) scavenging activity, superoxide radical scavenging activity and 
hydrogen peroxide scavenging activity, respectively (Liu et al., 2010; Ma et al., 2013; 
Shi et al., 2013) (Table 1). A low molecular weight β-1,3-glucan (LMG) was able to 
significantly increase the viability (from 40% to 80%) of a mouse leukaemic monocyte 
macrophage cell line (RAW 264.7) with H2O2-induced oxidative stress, reduced 
reactive oxygen species (ROS) formation and also suppressed the activities of neutral 
and acidic sphingomyelinases (SMases) (Kao et al., 2012). A homo-polysaccharide 
composed by mannose also had very interesting antioxidant activity under in vitro and 
in vivo conditions. This polysaccharide displayed promising free radicals (O2.-; HO. and 
DPPH) scavenging ability and was able to increase the activity of the antioxidant 
enzymes, SOD (from 67.4 to 115.4 U/mL and 140 to 230 U/mL), CAT (from 7.82 to 
13.91 U/mL and 13.0 to 22.0 U/mL) and GSH-Px (from 10.42 to 26.39 U/mL and 16.0 
to 36.0 U/mL), as well as decrease malondialdehyde (MDA) levels (from 16.0 to 8.0 
mmol/mL) in rats with cervical and ovarian carcinomas (YouGou et al., 2009; XiaoPing 
et al., 2009). Zhonghui et al. (2013) studied the antioxidant capacity of a G. lucidum 
polysaccharide (GL-PS) against exercise-induced oxidative stress, which was related 
with the dose; the activity of the antioxidant enzymes significantly increased: SOD 
(from 110 to 170 U/mg protein), CAT (from 1.58 to 1.95 U/mg protein) and GSH-Px 
(from 6.0 to 15.0 U/mg protein), while the levels of MDA decreased (from 8.2 to 4.8 
nmol/mg protein). A hetero-glucan also isolated from G. lucidum showed antioxidant 
activity against mitochondria oxidative injury induced by γ-irradiation, causing a drastic 
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decrease in MDA (from 1.24 to 0.55 nmol/mg protein), lipid hydroperoxides (LOOH) 
(from 1.09 to 0.04 nmol/mg protein) and protein carbonyl formation (from 0.84 to 0.22 
nmol/mg protein), while protein thiol formation increased (from 9.28 to 13.42 nmol/mg 
protein). This hetero-glucan also increased the activity of the antioxidant enzymes SOD 
(from 3.07 to 6.11 U/mg protein), CAT (from 3.25 to 7.08 U/mg protein) and GSH-Px 
(from 2.66 to 4.77 U/mg protein) (Li et al., 2007). The main linkages in the homo-
glucans were β-(1-3), (1-4) and (1-6) glycosidic bonds, as also in hetero-glucans, 
composed of different sugars, such as mannose, glucose, rhamnose, galactose, 
galactose, xylose, arabinose and fucose in different proportions. Liu et al. (2010) 
isolated a homo-glucan and a hetero-glucan, both low molecular weight 
polysaccharides, and reported a higher antioxidant activity of the homo-glucan because 
of its lower molecular weight. Nevertheless, Ma et al. (2013) isolated hetero-glucans 
with different molecular weights, and the polysaccharide with the highest molecular 
weight gave the highest antioxidant activity.  
 
3.2. Ganoderma glycopeptides  
There are several reports on the in vitro and in vivo antioxidant activity of glycopeptides 
obtained from Ganoderma sp. (Yu-Hong et al., 2002; Zhang et al., 2003; Sun et al., 
2004; Zhao et al., 2004; Chen et al., 2008; Jia et al., 2009; Li et al., 2009; Li et al., 
2010; Li et al., 2011; Li et al., 2012a). 
The most abundant component isolated from G. atrum (PSG-1) is a glycoprotein with a 
molecular weight of 1.013 KDa, composed of 10.1% of protein with 17 general amino 
acids, and different sugars namely, mannose, galactose and glucose linked by O-
glycosidic linkages (Chen et al., 2008). PSG-1 was studied for its antioxidant activity 
against anoxia/re-oxygenation injury in neonatal rat cardiomyocytes, anoxia/re-
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oxygenation-induced oxidative stress in mitochondrial pathway, oxidative stress 
induced by D-galactose in mouse brain, and age-related oxidative stress in mice. The 
authors reported very potent antioxidant activity by protecting cardiomyocytes from 
anoxia/re-oxygenation. It significantly increased the activity of antioxidant enzymes, 
decreased the levels of MDA, and attenuated ROS formation, thereby having the 
potential to promote health and improve aging-associated pathologies by modifying the 
redox system and improving the immune function (Li et al., 2009; Li et al., 2010; Li et 
al., 2011; Li et al., 2012a).  
Yu-Hong et al. (2002) studied the antioxidant activity of a glycopeptide (GLP) isolated 
from G. lucidum against the injury of macrophages induced by ROS. It was composed 
of 14 amino acids, D-rhamnose, D-xylose, D-fructose, D-galactose, D-mannose, and D-
glucose as sugars, linked by β-glycosidic linkages, and with a molecular weight of 
0.585 KDa. GLP showed in vitro and in vivo antioxidant activity by increasing the 
survival rate of macrophages, and protecting the mitochondria against injury by 
membrane-permeant oxidant (tBOOH). GLP was also studied for its antioxidant activity 
on streptozotocin (STZ)-diabetic rats, being able to increase non-enzymatic and 
enzymatic antioxidants, serum insulin level and to reduce lipid peroxidation (Jia et al., 
2009).  
Sun et al. (2004) studied GLP antioxidant activity in different oxidation systems 
(soybean and lard oils as oxidation substrates), and described an excellent activity 
comparable to the synthetic antioxidant butylated hydroxytoluene (BHT) in soybean oil. 
This glycopeptide was able to block soybean lipoxygenase activity, showed scavenging 
activity toward hydroxyl radicals produced in a deoxyribose system, quenched 
superoxide radical ion produced by pyrogallol autoxidation, displayed antioxidant 
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activity in rat liver tissue homogenates and mitochondrial membrane peroxidation 
systems, and also blocked the auto-hemolysis of rat red blood cells.  
A glycopeptide isolated from G. lucidum, with a molecular weight of 0.5849 KDa, 
composed of 17 amino acids and rhamnose, xylose, fructose, galactose, mannose and 
glucose as sugars, linked by β-glycosidic linkages, had antioxidant activity by reducing 
ROS formation, MDA levels and increasing the activity of manganese superoxide 
dismutase in rat cerebral cortical neuronal cultures exposed to hypoxia/re-oxygenation 
(Zhao et al., 2004). This glycopeptide also showed antioxidant activity (free radicals 
scavenging ability) by protecting against alloxan-induced pancreatic islets damage 
under in vitro and in vivo conditions (Zhang et al., 2003).  
 
3.3. Crude polysaccharidic Ganoderma extracts  
The antioxidant activity of crude polysaccharidic extracts obtained from Ganoderma 
sp., have been recently described (Shi et al., 2010; Yang et al., 2010; Heleno et al., 
2012; Kozarski et al., 2012; Zhao et al., 2012; Pan et al., 2013). 
A polysaccharidic extract from G. lucidum showed antioxidant activity in rats with 
gastric cancer by increasing the activity of antioxidant enzymes (SOD, CAT and GSH-
Px) (Pan et al., 2013). Other polysaccharidic extracts, also obtained from G. lucidum, 
displayed radicals scavenging ability, reducing power and lipid peroxidation inhibition, 
with the extract obtained from spores as the most effective (Heleno et al., 2012). 
Kozarski et al. (2012) reported the antioxidant activity of polysaccharidic extracts from 
G. applanatum and G. lucidum namely, radicals scavenging activity, reducing power, 
lipid peroxidation inhibition and chelating abilities.  
Zhao et al. (2012) reported the radio-protective effects of a G. lucidum polysaccharidic 
extract on mouse deoxyribonucleic acid (DNA) damage induced by cobalt-60 gamma-
irradiation, and described that DNA strand-break and micronuclei frequency were 
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significantly reduced, while GSH-Px activity and nucleated cell count in bone marrow 
significantly increased. This polysaccharidic extract also increased SOD activity and 
decreased MDA levels. 
Polysaccharidic extracts prepared from G. lucidum also lowered serum levels of MDA 
and intercellular adhesion molecule-1 in heart and liver of mice with ischemic 
reperfusion, and increased antioxidant enzymes activity (Shi et al., 2010). In diabetic 
rats, the polysaccharidic extract was able to reduce oxidative injury and inhibit 
apoptosis by increasing antioxidant enzymes activity, and modifying B-cell lymphoma 
2 (bcl-2) expression and bcl-2-associated X protein (bax)/bcl-2 ratio (Yang et al., 2010).  
The studies performed over the last decades concerning antioxidant properties of 
polysaccharides, glycoproteins and crude extracts described that the radicals scavenging 
activity seems to be mostly related with the increase in the activity of antioxidant 
enzymes such as SOD, CAT and GSH-Px (Yu-Hong et al., 2002; XiaoPing et al., 2009; 
YouGuo et al., 2009; Pan et al., 2013).   
There are not many studies on the antioxidant activity of Ganoderma polysaccharides, 
and the existing ones only report polysaccharides from G. lucidum. Most of these 
studies were carried out under in vitro conditions; and reports using in vivo assays are 
scarce and do not describe the mechanism of action involved. Instead, they only 
describe an increase in antioxidant enzymes activity after exposure to a specific injury. 
Additionally, those polysaccharides were isolated but not completely chemically 
characterized. The available data generally include molecular weights and, in some 
cases, sugars composition; glycosidic linkages are rarely characterized. Therefore, it is 
not possible to highlight a key chemical feature directly related with the antioxidant 
activity of Ganoderma polysaccharides, since there is a lack of information on their 
chemical characteristics. Based on the existing reports with available information about 
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structural features, it can only be speculated that homo-glucans and hetero-glucans with 
β (1→3) glycosidic linkages have strong antioxidant properties (Liu et al., 2010; Kao et 
al., 2012). 
 
4. Antitumor Ganoderma polysaccharides 
4.1. Ganoderma polysaccharides  
The crude water-soluble extract of G. lucidum has been used in traditional Chinese 
medicine as antitumor and immunomodulating agent (Zong et al., 2012). Most reports 
concerning the antitumor activity of polysaccharides from Ganoderma demonstrate that 
it is mainly related to the host-mediated immune function (Gao et al., 2005a; Paterson, 
2006). Ganoderma polysaccharides have received special attention from the scientific 
community, especially those from the species G. lucidum, and their antitumor activity 
has been studied both in vitro and in vivo.  
Hence, bioactive polysaccharides have been isolated from the fruiting bodies of G. 
lucidum (Bao et al., 2002; Zhao et al., 2010) and from the mycelia cultivated in liquid 
culture medium (Kim et al., 1993; Peng et al., 2005; Liu et al., 2012). Some 
polysaccharides have also been isolated from the culture medium of growing mycelium 
(extracellular polysaccharides) (Sone et al., 1985). 
Antitumor effects of polysaccharides isolated from G. lucidum, such as the branched 
heteroglucan, arabinoxyloglucan (GL-1), were initially observed in subcutaneously 
transplanted sarcoma-180 ascites growing in mice (Miyazaki and Nishijima, 1981; 
Table 2). This polysaccharide contains a backbone and side-chains involving D-
glucopyranosyl, α-(1→4), β-(1→6) and β-(1→3) linkages; arabinose is present as a part 
of the non-reducing terminal residues, and xylose is present as a part of the side-chain. 
This hetero-glucan strongly inhibited the growth of sarcoma-180 solid-type tumor 
(inhibition ratio, 95.6 - 98.5%) after intra-peritoneal injection (20 mg/Kg) for 10 days in 
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imprinting control regions (ICR) of mice (Miyazaki and Nishijima, 1981; Table 2). 
Sone et al. (1985) also described the antitumor activity of G. lucidum polysaccharides 
either from the fruiting bodies or the mycelium against sarcoma-180 solid tumor. Once 
again, the studied polysaccharides had (1→3)-β-D-glucan bonds and some (1→4)-
linked glucosyl units (Table 2).   
The antitumor potential of Ganoderma polysaccharides is usually related to their 
immunomodulatory activity. Since polysaccharides have a large molecular weight, these 
compounds cannot penetrate cells, but they bind to immune cell receptors. It has been 
proven that there are fungal pattern-recognition molecules for the innate immune 
system. However, the mechanism by which the innate immune system recognizes and 
responds to fungal cell wall carbohydrates is a very complex and multifactorial process 
(Lowe et al., 2001).  
Yan and collaborators suggested that the activity of polysaccharides from G. lucidum 
was mediated through the complement receptor type 3 (CR3 receptor), which binds β-
glucan polysaccharides (Yan et al., 1999). Indeed, G. lucidum polysaccharide (GLP), 
known as a homo-glucan from G. lucidum, isolated by hot aqueous extraction and 
ethanol precipitation from the fruiting bodies of this medicinal mushroom, exerted its 
antitumor activity in sarcoma-180 solid tumor by inducing a cascade of immuno-
modulatory cytokines. It could induce a marked increase in the gene expression levels 
of IL-lα (2-fold), IL-lβ (3-fold), TNF-α (2-fold), IL-12 p35 (up to 6-fold), and IL-12 
p40 in the splenocytes. In the macrophages, GLP promoted a remarkable increase in the 
gene expression levels of IL-lβ (2.5- to 3-fold), TNF-α (up to 6-fold), and granulocyte-
macrophage colony-stimulating factor (GM-CSF) (up to 2-fold) (Ooi et al., 2002; Table 
2). GLP also exhibited antitumor effects on solid tumor induced by Ehrlich’s ascites 
carcinoma cells. Indeed, 100 mg/kg of this polysaccharide showed 80.8% and 77.6% 
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reduction in tumor volume and tumor mass, respectively, when administered 24h after 
tumor cell implantation. Moreover, GLP with the same dose but administered prior to 
tumor inoculation, showed 79.5% and 81.2% inhibition of tumor volume and tumor 
mass, respectively (Soniamol et al., 2011). GLP not only has (1→3)-β-D-glucan bonds, 
but also has (1→6)-β-D branches. Furthermore, structural features such as (1→3)-β- 
linkages in the main chain of the glucan, and additional (1→6)-β-branch points, seem to 
be important factors for the observed antitumor activity.  
The same features were verified for the heteroglucans from G. tsugae described by Peng 
et al., (2005), which were composed by (1→3)-β-D-glucans and (1→4)-α-D-glucans 
and also possess antitumor activity against sarcoma-180 solid tumor (Table 2). 
Actually, the fruiting body of G. tsugae is used to promote health and longevity in 
Oriental countries (Haghi, 2011), which can be, in part, justified for these findings. 
More recently, other heteropolysaccharides from Ganoderma  have been studied both in 
vivo and in vitro, establishing inhibitory activity in tumor cell lines, apoptosis induction 
and inhibition of tumors transplanted in mice (Liu et al., 2012; Zhang et al., 2012; Ma et 
al., 2013;Table 2).   
Other polysaccharides from G. lucidum with immunomodulatory properties have been 
described, namely PG-1 and PG-2, which increased the proliferation and pinocytic 
activity of macrophages and played an inhibitory effect on the growth of a human breast 
cancer cell line (MDA-MB-231) (Zhao et al., 2010; Table 2). 
There are also reports on the antitumor potential of other polysaccharides from 
Ganoderma species but without their chemical characterization.  For example, other 
authors reported the antitumor properties of mannogalactoglucans and (1→3)-β-
glucuronoglucans from G. lucidum tested in vitro (in cell lines) and of glucogalactans 
from G. tsugae tested in vivo (pre-clinical animal models), through their 
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immunomodulatory activity (Zhuang et al., 1994; Cho et al., 1999; Wasser, 2002; 
Moradali et al., 2007; Zhang et al., 2007; Ferreira et al., 2010).  
 
4.2. Ganoderma polysaccharide-protein or -peptide complexes  
As mentioned above, polysaccharides isolated from Ganoderma may be also bound to 
protein or peptide residues. These polysaccharide-protein or -peptide complexes have 
also been described as having antitumor properties. G. lucidum polysaccharide peptide 
(GLPP), potently inhibited human lung carcinoma cell line (PG), proliferation in vitro 
and reduced the xenograft (of the PG cell line) in albino laboratory-bred strain of the 
house mouse (BALB/c) nude mice in vivo. This compound proved to have anti-
angiogenic activity, which can be the basis of its antitumor effects.  This 
polysaccharide-peptide with relative molecular weight (MW) of 512500, is composed 
by D-rhamnose, D-xylose, D-fructose, D-galactose, and D-glucose linked together by β-
glycosidic linkages (Cao and Lin, 2004).  
A fucose-containing glycoprotein fraction from the water-soluble extract of G. lucidum 
seems also to be responsible for its immunomodulating and antitumor activities through 
the stimulation of the expression of cytokines, especially IL-1, IL-2 and IFN-γ (Wang et 
al., 2002). Although the active fraction contained the majority of D-glucose, D-mannose 
and D-galactose, the only active component identified in the glycopeptide fraction 
contained fucose residues. In addition, the crude extract of G. lucidum did not stimulate 
expression of cytokines, whereas the glycoprotein fraction significantly induced 
expression of IL-1, IL-2, and IFN-γ (Wang et al., 2002). 
A well-known proteoglycan from G. lucidum is the previously mentioned GLIS 
(Section 2.1). This proteoglycan with a molecular weight of about 2000 kDa, and 
carbohydrate portion consisting of hetero-polysaccharides composed predominantly of 
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D-glucose, D-galactose and D-mannose, exhibits an effective antitumor effect by 
increasing both humoral and cellular immune activities (Zhang et al., 2010). 
A water-soluble protein-bound polysaccharide from the fruiting bodies of G. atrum 
(PSG-1), besides the antioxidant properties previous reported, displayed potent 
antitumor activity in sarcoma180 transplanted mice by induction of tumor apoptosis 
through mitochondrial pathways, and its antitumor effect was related to immuno-
enhancement (Li et al., 2011a). This compound, proved to improve immunity by 
inhibiting proliferation of a mouse colon carcinoma cell line (CT26) via activation of 
peritoneal macrophages. In vivo, PSG-1 considerably suppressed the tumor growth in 
CT26 tumor-bearing mice (Zhang et al., 2013). 
A G. lucidum polysaccharide-peptide conjugate with a molecular weight of 0.5125 KDa 
and polysaccharide chain assembled in β-glycosidic linkages, also exhibited antitumor 
potential in different studies. For example, it significantly inhibited tumor growth in a 
murine sarcoma180 model, and inhibited proliferation of Human Umbilical Vein 
Endothelial Cells (HUVECs) by inducing cell apoptosis and decreasing the expression 
of secreted vascular endothelium growth factor (VEGF) in human lung cancer cells (Li 
et al., 2008; Cao and Lin, 2006).  
 
4.3. Ganoderma polysaccharidic extracts/fractions  
Polysaccharidic fractions from Ganoderma have also been described as having potential 
antitumor activity. Ganopoly is one of the most well-known aqueous polysaccharidic 
fractions from G. lucidum with antitumor potential. Treatment of mice with Ganopoly 
for 10 days could significantly reduce tumor weight in a dose-dependent manner in S-
180-bearing mice. Furthermore, the polysaccharide caused significant cytotoxicity in 
the human tumor cell lines: Human Caucasian Cervical Epidermoid Carcinoma (CaSki), 
	   24	  
Human Cervical Cancer (SiHa), Human Hepatoma (Hep3B), Human Hepatocellular 
Liver Carcinoma (HepG2), Human Colon Carcinoma (HCT116) and Human Colon 
Adenocarcinoma Grade II (HT29) Cells in vitro, with marked apoptotic effects observed 
in CaSki, HepG2 and HCT116 cells (Gao et al., 2005a). Other studies showed that 
Ganopoly could enhance immune responses in patients with advanced-stage cancer, 
which could be an approach for overcoming immunosuppressive effects of 
chemotherapy/radiotherapy (Gao et al., 2003b; Gao et al., 2005b). 
Some studies also suggest that antitumor activity of polysaccharides from fresh fruiting 
bodies of G. lucidum (PS-G), is achieved through stimulation of the production of IL-
1β, TNF-α, and IL-6 from human monocyte-macrophages and IFN-γ from T 
lymphocytes. These studies were carried out in the human promyelocytic leukaemia 
(HL-60), and human lymphoma cell lines (U937) (Wang et al., 1997). G. lucidum 
polysaccharide (GL-B), consisting of seven fractions of polysaccharides isolated from 
this species, was tested both in vitro (HL-60, and sarcoma-180 cells), and in vivo 
(sarcoma-180 cells injected sub-dermally into the axillary fossa of the right foreleg of 
BALB/c mice), and this established that its antitumor potential is also related to TNF-α 
and IFN-γ (Zhang and Lin, 1999). Co-administration of G. lucidum polysaccharides and 
cyclophosphamide potentiated the antitumor activity of this drug (used to treat cancer 
and immune diseases) in mice. These results indicate that either G. lucidum or its active 
components have antitumor activity in mice, and that Ganoderma polysaccharides have 
a synergic effect on the antitumor activity of cyclophosphamide (Lin and Zhang, 1999). 
G. tsugae mycelium and fruiting body polysaccharidic fractions have also been 
investigated. Seven glycans with strong antitumor activities were obtained from 14 
water-soluble and 15 water-insoluble fractions extracted from G. tsugae fruiting bodies.  
The bioactivity against sarcoma-180/mice was tested, and tumor inhibition ratios from 
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26.1 to 100% were observed (Wang et al., 1993). Water-soluble fractions were protein-
containing glucogalactans associated mainly with mannose and fucose, but also 
containing arabinose and rhamnose; water-insoluble fractions represented protein-
containing β-(1→3)-glucans with different protein content and some of them with 
(1→6)-β-D-glucosyl branched chains. The molecular weight averages ranged from 8 × 
103 to 700 × 103 (Wang et al., 1993). Sixteen water-soluble polysaccharides were 
extracted from G. tsugae mycelium and examined for their antitumor effects on 
sarcoma-180 in mice (Zhang et al. 1994). The active polysaccharides obtained were: i) a 
glycan-protein complex containing 9.3% protein, with a hetero-glyco-chain of mannose 
and xylose; ii) a glucan-protein complex containing 25.8% protein and iii) a glycan-
protein with glucose as the main component, and associated with arabinose, mannose, 
xylose, and galactose. The molecular weight ranged from 10 ×10-3 to 16 ×10-3 (Zhang et 
al. 1994). Comparison of active water-soluble polysaccharides obtained from the 
fruiting body and mycelium showed that the first were gluco-galactan-protein 
complexes, but those of the mycelium were homo-glucan-protein complexes or a 
hetero-glycan composed of mannose and xylose (Wasser, 2002). However, and once 
again, the structure with β-(1→3)-glucans and, in some cases, with (1→6)-β-D-glucosyl 
branched chains was present in these bioactive polysaccharidic fractions.   
Other polysaccharidic fractions were also obtained from the water soluble extracts of G. 
applanatum. These preparations had antitumor properties against transplanted sarcoma-
180 in mice, and, for one of the obtained fractions, a complete regression of tumors was 
observed in more than half of animals; inhibition ratios were over 95%, with no sign of 
toxicity (Sazaki et al., 1971). These fractions were considered to be a glucan consisting 
partially of a mixture of β-(1→3) and (1→4) linked D-glucose residues.  
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Polysaccharidic extracts from the mycelium of G. lucidum also exhibited antitumor 
effects against fibrosarcoma in male and female mice and inhibited the metastasis of a 
lung tumor. 
Different studies showed that bioactive polysaccharides and extracts could stimulate 
blood mononuclear cells to increase cytokines, tumor necrosis factor, interferon and 
interleukins production, induce apoptosis and meaningfully increased the lifespan of the 
tumor-implanted mice (Paterson, 2006; Ramberg et al., 2010; Roupas et al., 2010; Liao 
et al., 2013). 
 
4.4. Structure-bioactivity relationship 
Polysaccharides are one of the biologically active groups of compounds found in 
mushrooms, namely in Ganoderma genus, which have antitumor properties (Wasser, 
2002; Lindequist et al., 2005; Paterson, 2006; Ferreira et al., 2010; Patel and Goyal, 
2012; Nie et al., 2013). Thus, Ganoderma has been considered a bioactive therapeutic 
fungus (Paterson, 2006) and its antitumor potential has been explored (Wang et al., 
1997; Yuen and Gohel, 2005).  
The study and description of the chemical features of Ganoderma polysaccharides are 
very important as they allow us to infer or deduce structure-bioactivity relationships. 
Different polysaccharides from the Ganoderma genus have been isolated and 
characterized especially in the past three decades. 
The first reports of Ganoderma polysaccharides structure date back to 1981, when 
Miyazaki and Nishijima characterized a water-soluble branched arabinoxyloglucan from 
G. lucidum, which contained β-(1→4)-, β-(1→6)-and β-(1→3)-D-glucopyranosyl 
residues in the backbone and side-chains. These authors inferred that the essential 
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structure for the antitumor activity of polysaccharides from Ganoderma might be a 
branched glucan core involving (1→3)-β-, (1→4)-β- and (1→6)–β- linkages. 
More recently, Bao et al. (2002) isolated three polysaccharides, two heteroglucans (PL-
1 and PL-4) and one glucan (PL-3) from the fruiting bodies of the same species. This 
study showed that PL-1 had a backbone consisting of 1,4-linked α-D-glucopyranosyl 
residues and 1,6-linked β-D-galactopyranosyl residues with branches at O-6 of glucose 
residues and O-2 of galactose residues, composed of terminal glucose, 1,6-linked 
glucosyl residues and terminal rhamnose, respectively. PL-3 was a highly branched 
glucan composed of 1,3-linked β-D-glucopyranosyl residues substituted at O-6 with 
1,6-linked glucosyl residues. PL-4 was comprised of 1,3-, 1,4-, 1,6-linked β-D-
glucopyranosyl residues and 1,6-linked β-D-mannopyranosyl residues. More recently, 
Wang et al. (2011) isolated five water-soluble heteropolysaccharides from the cultured 
fruiting body of G. lucidum, designated as GL-I to GL-V. These compounds proved to 
be heteropolysaccharides, mainly composed of glucose, galactose, mannose and 
arabinose. GL-I was the most branched of the heteropolysaccharides (27.0% degree of 
branching), while GL-V was mostly a linear glucan.  
The biological activity/antitumor potential of polysaccharides seems to be highly 
correlated with their chemical composition and configuration, as well as their physical 
properties, being exhibited by a wide range of glycans extending from homopolymers to 
highly complex heteropolymers (Ooi and Liu, 1999). As stated initially by Miyazaki 
and Nishijima (1981), more recent studies continue to point to the importance of 
structural features such as (1→3)-β-linkages in the main chain of the glucan and 
additional (1→6)-β- branch points as essential factors for the antitumor activity of 
polysaccharides (Wasser, 2002). Therefore, β-glucans containing mainly 1→6 linkages 
exhibit less activity, possibly due to their inherent flexibility of having too many 
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possible conformations (Zhang et al., 2007; Ferreira et al., 2010). However, antitumor 
polysaccharides may have other chemical structures, such as hetero-β-glucans (Mizuno 
et al., 1995b), heteroglycan (Gao et al., 1996), β-glucan-protein (Kawagishi et al., 
1990), α-manno-β-glucan (Mizuno et al., 1995b), α-glucan-protein (Mizuno et al., 
1995b) and heteroglycan-protein complexes (Zhuang et al., 1993; Mizuno et al., 1996). 
It has been described that the antitumor activity of mushroom polysaccharides 
containing glucose and mannose may be due to their immunomodulating activity, since 
a polysaccharide receptor, which has been demonstrated to have high specificity for 
glucose and mannose, has been found on human macrophages (Lombard, 1994). Triple 
helical conformation of (1→3)-β-glucans is considered an important structural feature 
for their immuno-stimulating activity, but how the triple helical conformation of (1→3)-
β-glucan precisely affects their antitumor action still remains unclear. Indeed, (1→3)-β-
glucans exhibit antitumor activity related to their triple helical conformation (Zhang et 
al., 2007). 
Higher antitumor potential seems to be also correlated with higher molecular weight 
(Mizuno et al., 1996; Wasser, 2002), lower level of branching and greater water 
solubility of β-glucans (Ferreira et al., 2010). Thus, although other features such as 
molecular weight or level of branching are very important for the antitumor potential of 
the polysaccharides, the molecules described above have the main glycosidic bonds 
required for this activity, which seems to be highly related with the results obtained.  
The antitumor potential is the most explored bioactivity of Ganoderma polysaccharides, 
being extensively studied; the chemical structures are completely characterized, and 
even some mechanisms of action are proposed by some authors (Yan et al., 1999; Ooi et 
al., 2002). Analysing the available data, it can be highlighted that the essential structure 
for the antitumor potential of polysaccharides is a branched glucan core involving 
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(1→3)-β-, (1→4)-β- and (1→6)-β-linkages (Miyazaki and Nishijima, 1981). 
Nevertheless, clinical human trails are needed to better understand the bioactivity of 
these interesting and extremely potent molecules, so that the investigation can progress 
in order to use these molecules in the development of new nutraceuticals or drugs. 
 
4.5. Antioxidant and antitumor potential  
The antitumor activity of Ganoderma, namely G. lucidum, seems to be also strongly 
related with its antioxidant properties, since water soluble polysaccharides extracted 
from G. lucidum were effective in preventing DNA strand breaks (Paterson, 2006). 
 An aminopolysaccharide fraction from G. lucidum (G009) was found to have the 
ability to protect against ROS, which is implicated in the pathophysiology of cancer 
(Pincemail, 1995). G009 inhibited iron-induced lipid peroxidation and inactivated 
hydroxyl radicals and superoxide anions. Furthermore, G009 also reduced oxidative 
DNA damage, suggesting that the aminopolysaccharide fraction of G. lucidum 
possesses chemopreventive potential (Lee et al., 2001).  
Two cerebrosides (glycosphingolipids consisting of D-glucose, sphingosine and 2-
hydroxypalmitoyl or 2-hydroxystearoyl fatty acid moiety, respectively), were also 
isolated from the fruiting body of G. lucidum (Mizushina et al., 1998). Both molecules 
inhibited DNA polymerases, suggesting their possible use for cancer therapy by 
inhibiting DNA replication (Sliva, 2003). 
With all the studies conducted so far, polysaccharides have been suggested to have an 
ability to enhance the host’s defense system in both antioxidant and antitumor abilities 
(Mizuno et al., 1995a; Pan et al., 2013). The work performed so far, especially in G. 
lucidum, indicates that fractions of polysaccharides were not as effective as their 
equivalent dose in the crude extract of the whole mushroom, suggesting that the 
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bioactivity of this medicinal mushroom may be due to the synergistic effects of multiple 
compounds, such as triterpenes (Liu et al., 2002). This idea is supported by some 
studies, such as the study in which a polysaccharidic mixture containing isoflavone 
aglycones produced from the cultured mycelia of G. lucidum inhibited angiogenesis in 
BALB/c mice with implanted chambers containing a suspension of colon-26 cells 
(Miura et al., 2002).  
 
5. Antimicrobial Ganoderma polysaccharides 
5.1. Medicinal mushrooms as antimicrobial agents 
Fungi are well known for the production of important antibiotic compounds, such as 
penicillin. However, the occurrence of antibiotics in the class of fungi known as 
mushrooms is less well documented (Miles and Chang, 1997). Mushrooms belong to 
the kingdom of Fungi, they were thought to have weak antifungal activities (Mizuno, 
1995) and therefore have rarely been investigated for their bioactivity as antifungal 
agents. It is only recently that they have become of interest due to their secondary 
metabolites exhibiting a wide range of antimicrobial activities. 
Ganoderma species have been widely investigated for their therapeutic properties as 
antitumor and antiviral agents but have been far less investigated as a source of new 
antibacterial agents. A review by Gao et al. (2003a) on the antibacterial and antiviral 
value of Ganoderma species supported this observation, as there were few citations on 
research in this area. It is interesting to note that the majority of antibacterial 
investigations on Ganoderma species have been performed on the fruiting body and 
there are relatively few on extracts from the liquid cultivated mycelium. 
 
5.2. Current antimicrobial research on Ganoderma species  
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Western and Eastern medicine have adopted different regulatory systems for herbal and 
mushroom preparations (Wasser, 2011). Western medicine has made little use of 
medicinal mushroom products partly due to their complex structure and lack of 
acceptable pharmacological purity (Sullivan et al., 2006). In the search for 
microbiologically active compounds from Ganoderma species, the majority of research 
has been performed on extracts from the fruiting body and mycelium, and there are a 
few studies on antimicrobial activity of isolated fractions or pure polysaccharides. It 
appears that there are a number of biologically active compounds to be found in the 
mycelium and fruiting body, but antimicrobial activity evaluation of chemically 
characterized polysaccharides is very limited. It could be only noted that (1→3)-β-D-
glucan with (1→6)-β-D branches could act as antimicrobial agent in vivo. 
 
5.3. Antibacterial activity of Ganoderma polysaccharides 
The antibacterial activity of polysaccharides from G. lucidum fruiting bodies was 
reported (Table 3) (Skalicka-Woźniak et al., 2012). Thirty six samples were analyzed. 
Four strains of G. lucidum (GL01, GL02, GL03 and GL04) were cultivated on the 
growth substrates of three different sawdust types: birch (Bo), maple (Kl) or alder (Ol) 
amended with wheat bran in three different concentrations: 10, 20 and 30% (w/w). Even 
though the richest in polysaccharides was the GL01 strain, the highest yields of the 
polysaccharides were observed in the GL04Kl3 sample (112.82 mg/g of dry weight). 
The antibacterial activity of the polysaccharides was determined in vitro using the 
micro-dilution broth method. A panel of eight reference bacterial strains was used and 
all the tested polysaccharides showed moderate antibacterial activity. The Micrococcus 
luteus American Type Culture Collection (ATCC) 10240 strain was the most sensitive 
with minimal inhibitory concentrations (MICs) 0.63-1.25 mg/mL. Nevertheless, the 
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analyzed polysaccharides exhibited inhibitory effects against all the bacterial strains 
tested, with MICs ranging from 0.62 to 5.0 mg/mL. The minimal bactericidal 
concentrations (MBCs) of the samples were comparable (2.5 or 5.0 mg/mL). Only slight 
differences were observed between MICs and MBCs of the polysaccharide samples 
obtained from the strains of the G. lucidum fruiting bodies, and the ones obtained from 
the sawdust cultivation substrates. The low MBC/MIC ratios suggest that 
polysaccharides acted as bactericidal agents. The screening of antibacterial activity 
indicates that there were no significant differences in the antimicrobial activity between 
the polysaccharides obtained from the four strains of G. lucidum fruiting bodies and the 
ones obtained from different sawdust cultivation substrates. The polysaccharides tested 
exerted the strongest inhibitory effect towards M. luteus (MIC 0.62 or 1.25 mg/mL) 
(Skalicka-Woźniak et al., 2012). 
In another study, G. lucidum polysaccharides were extracted with boiling water, and 
further tested for antimicrobial activity against three plant pathogens (Erwinia 
carotovora, Penicillium digitatum, Botrytis cinerea) and five food harmful 
microorganisms (Bacillus cereus, Bacillus subtilis, Escherichia coli, Aspergillus niger 
and Rhizopus nigricans) by the agar diffusion method. The results showed that the 
polysaccharide liquid had a powerful inhibitory effect on E. carotovora, a weak 
inhibitory effect on P. digitatum and a nearly non-inhibitory effect on B. cinerea, for the 
plant pathogens. Regarding food harmful microorganisms, the polysaccharide liquid had 
a strong inhibitory effect on B. subtilis and B. cereus, a weak inhibitory effect on E. coli 
and A. niger, and a nearly non-inhibitory effect on R. nigricans (Bai et al., 2008). 
Polysaccharides from the mycelia and basidiocarp of Ganoderma applanatum were 
found to possess activity against Acitenobacter aerogenes, Acrobacter aerogenes, 
Arthrobacter citreus, Bacillus brevis, B. subtilis, Corynebacterium insidiosum, E. coli, 
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Proteus vulgaris, Clostridium pasteurianum, Micrococcus roseus, Mycobacterium 
phlei, Sarcina lutea and Staphylococcus aureus (Bhattacharyya et al., 2006). 
The extracellular polysaccharides obtained from Ganoderma formosanum culture 
medium were separated into three major fractions, PS-F1, PS-F2, and PS-F3, based on 
their molecular size (Wang et al., 2011a). Although the different monosaccharide’s 
composition in each fraction, D-mannose was the major constituent among all fractions, 
and in the two major fractions PS-F2 and PS-F3, the second most abundant sugar was 
D-galactose, followed by D-glucose. G. formosanum thus synthesizes a different form 
of polysaccharide as compared with other Ganoderma species (e.g., G. lucidum) in 
which D-glucose is usually the major component (Wang et al., 2002). These results 
show that D-mannose and D-galactose are the major constituents of G. formosanum 
polysaccharides. The differences in carbohydrate composition among fungal 
polysaccharides could be due to strain variations or caused by different ways of 
cultivation (solid-state culture versus liquid-state culture). The polysaccharides were 
produced in a submerged mycelial culture. The fungal cell wall polysaccharides 
synthesized under different growth conditions may exhibit different biological effects. 
Methods of extraction may also affect the polysaccharides obtained from G. lucidum 
fruiting bodies, which could contain either β-1,3-glucans or α-1,4-linked polymannose 
(Miyazaki and Nishijima, 1981). It appears that both the sugar components and 
structures of the hetero-polysaccharides in the fungal cell wall are diverse and 
complicated. It is suggested that the extracellular polysaccharides of G. formosanum 
(PS-F2, and perhaps PS-F1 and PS-F3) have the potential to be used as immuno-
stimulatory and antibacterial agents against Listeria monocytogenes injected in mice. 
In the study of antibacterial activity of exopolysaccharide (EPS) from basal medium and 
malt medium obtained from different mushrooms, G. lucidum EPS showed the highest 
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activity against the growth of B. cereus among other bacterial species (23 ± 0.61 mm 
and 18 ± 0.38 mm, respectively) (Mahendran et al., 2013).  
Ganoderma polysaccharides have not been much studied regarding antimicrobial 
properties. Nevertheless, the available studies report mainly their activity against several 
pathogenic bacteria. Several authors reported antimicrobial activity of G. lucidum 
different extracts but not isolated polysaccharides (Sheena et al., 2003; Quereshi et al., 
2010). Heleno et al. (2013) reported strong antibacterial, antifungal and also 
demelanizing properties of G. lucidum extract, even better than the standards ampicillin 
and streptomycin in some cases. Thus, polysaccharides isolated from these species 
should also be analyzed since they can have a strong participation in the antimicrobial 
properties exhibited by G. lucidum.   
 
6. Ganoderma polysaccharides with non-reported bioactivity 
Polysaccharides from Ganoderma species with previously non-reported bioactivity are 
briefly discussed here. The reported polysaccharides with non-tested bioactivity belong 
to alkali-soluble polysaccharides and/or water insoluble polysaccharides and water 
soluble polysaccharides (Table 4).  
The methods for isolation, purification and identification are given in Table 4, as well 
as sugars composition and molecular weight. A water insoluble, but alkali-soluble 
glucan G-A was previously isolated from G. japonicum. (Ukai et al., 1982). Chen et al., 
(1998) have isolated water-insoluble glucans, namely GL4-1 and GL4-2 from the 
fruiting bodies of G. lucidum. A water soluble and low branched polysaccharide (SGL-
III) was isolated from the spores of G. lucidum (Zhao et al., 2005). A neutral, water 
soluble, heteropolysaccharide (GLPS3) was isolated from germinating spores of G. 
lucidum (Zhang et al., 2006). A water soluble β-glucan (DESSK5) was reported in the 
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basidiocarp of G. resinaceum (Amaral et al., 2008). A water soluble polysaccharide, 
heteropolysaccharide LZ-C-1 was isolated from G. lucidum (Ye et al., 2009). Neutral 
polysaccharide, soluble in water was isolated by Huang et al., (2011) from G. lucidum 
fruiting body. Novel heteropolysaccharides (GL-1 to GL-5) were also isolated from the 
fruiting bodies of G. lucidum (Wang et al., 2011a). Finally, a novel water soluble and 
neutral β-D-glucan (GLSA50-1B) was isolated from the spores of G. lucidum (Dong et 
al., 2012). 
The chemical features of the described polysaccharides with non-reported bioactivity 
are similar to the ones described for the polysaccharides with some reported 
bioactivities. These substances might be further used for evaluation of its biological 
potential, as their chemical properties are promising. 
 
7. Concluding remarks  
The beneficial health properties of Ganoderma species have been attributed to a wide 
variety of bioactive components present in this genus, such as polysaccharides. Most of 
the studies to date have focused on this class of compounds, since they have a 
considerable capacity for carrying biological information due to their high structure 
variability.   
Over the last three decades, many polysaccharides from Ganoderma species have been 
extracted by different methodologies according to their structure, water-solubility and 
mainly according to their cell wall structure. Therefore, polysaccharides have been 
extracted mostly by hot water and have been isolated and identified by different 
chromatographic techniques, such as mass spectroscopy or nuclear magnetic resonance. 
The α- or β-(1→3)-, (1→6)-glucans and hetero-polysaccharides with different 
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combinations of sugars have been extracted from different species, having molecular 
weights ranging from thousands to millions of Daltons. 
Polysaccharide structural features and bioactivities have been widely explored. These 
molecules have antioxidant, antitumor and antibacterial potential, which has been 
shown both in vitro and in vivo. These properties seem to be particularly related to 
polysaccharide molecular weight, level of branching, and water solubility. In all the 
studies reported, when a structure-activity relationship is considered, some 
characteristics of the polysaccharides may vary (e.g., molecular weight). For example, if 
the low molecular weight polysaccharides appeared to have higher antioxidant potential, 
more recent studies established that polysaccharides with a higher molecular weight 
also have this activity, as well as antitumor potential.  Concerning the sugars 
composition, homo and heteropolysaccharides composed by different sugars such as 
mannose, glucose, rhamnose, galactose, xylose, arabinose, fructose, or fucose and 
linked by β-glycosidic linkages revealed high bioactivity. So far, there is no uniformity 
in the structural features and characteristics of the bioactive polysaccharides. Moreover, 
besides the natural isolated polysaccharides, the polysaccharide-protein or –peptide 
complexes also present bioactivity, as well as polysaccharidic extracts or fractions, in 
which synergistic processes with other molecules improve the potential.  
Nevertheless, one feature seems to be common, and appears to be in the basis of the 
polysaccharide bioactivity: the glycosidic linkages. Indeed, features such as the (1→3)-
β-linkages in the main chain of the glucan and additional (1→6)-β- branch points, 
display higher bioactivity potential.  
Since these molecules were isolated and submitted to biological assays without 
complete chemical characterization, especially in the evaluation of antioxidant and 
antimicrobial activities, it is difficult to conclude what are the key chemical 
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characteristics for the bioactivities discussed. Accordingly, the best molecular weights 
cannot be specified, as also the sugars’ composition or level of branching that confer 
higher antioxidant, antitumor or antimicrobial potential to polysaccharides. Perhaps it is 
this variability that makes them such interesting compounds. With the reported studies, 
it can only be stated that the antioxidant properties of Ganoderma polysaccharides, 
particularly the radicals scavenging activity, seem to be more related with the increase 
of antioxidant enzymes (SOD, CAT and GSH-Px) activity, while the antitumor potential 
seems to be particularly related to the host’s immunity function, by exerting a series of 
immuno-enhancement properties, such as cytokine production. In some cases, the 
antitumor activity has been related to the antioxidant properties, since some 
polysaccharides extracted from G. lucidum have been shown to be effective in 
preventing DNA damage, suggesting a possible chemopreventive potential.  
There is not much data regarding the antimicrobial activity of polysaccharides from 
Ganoderma. However, the interest in this field has recently increased due to the 
discovery of secondary metabolites isolated from fungi, which have antimicrobial 
potential. Indeed, some polysaccharides from Ganoderma species have antibacterial 
activity, inhibiting bacterial growth or inducing death of pathogenic bacteria.  
Based on all the results herein reviewed, and although further testing is necessary (e.g., 
human clinical trials), the scientific evidence available to date suggests that Ganoderma 
may become a good health food supplement, namely for cancer patients. Nevertheless, 
the complete chemical characterization of the polysaccharides is of extremely 
importance so that it could be possible to better understand the main features 
responsible for their powerful abilities. Moreover, with that knowledge the investigation 
could be better conducted in order to develop new nutraceuticals and pharmacological 
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formulations such as the existing ones with G. lucidum extracts, glycoproteins or 
polysaccharides (Wang et al., 2006; Wong et al., 2006; Tu et al., 2011). 
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Table 1: Analytical procedures, chemical characterization and antioxidant activity of polysaccharides isolated from Ganoderma lucidum. 
Origin 
 
Extraction/isolation 
procedure 
Identification 
technique 
Polysaccharide 
type 
Main glycosidic 
bonds 
Sugars 
composition 
Molecular  
weight 
Antioxidant 
activity assays 
Antioxidant activity  
values 
References 
China 
(Fruiting body) 
(cultivated) 
Ultrasonic extraction; Sevag 
method; ethanol 
precipitation; ultrafiltration 
membranes 
HP-GPC; 
HPLC-FID; GC 
Heteroglucans 
(GLP, GLP1, 
GLP2, GLP3, 
GLP4) 
 
na Mannose; 
rhamnose; 
glucose; 
Galactose 
GLP- n.a.; 
GLP1- ˃10KDa; 
GLP2- 8-10 KDa; 
GLP3- 2.5-8 KDa; 
GLP4- ˂ 2.5 KDa 
 In vitro 
DPPH scavenging 
activity; 
Reducing power 
(RP); 
Fe2+chelating 
activity 
ORAC 
 
DPPH EC50 : GLP 0.28 mg/mL; GLP1 0.27 
mg/mL; GLP2 0.34 mg/mL; GLP3 0.42 
mg/mL; GLP4  ˃ 0.8 mg/mL 
 
RP EC50: GLP 0.42 mg/mL; GLP1 0.36 
mg/mL; GLP2 0.27 mg/mL; GLP3 0.36 
mg/mL; GLP4  ˃ 0.5 mg/mL 
 
Fe2+ EC50: GLP 0.10 mg/mL; GLP1 0.07 
mg/mL; GLP2 0.07 mg/mL; GLP3 0.06 
mg/mL; GLP4 0.058 mg/mL 
 
ORAC: GLP 1200  µmol trolox/g; GLP1 
1500 µmol trolox/g; GLP2 1780 µmol 
trolox/g; GLP3 1400 µmol trolox/g; GLP4 
1300  µmol trolox/g 
Ma et al., 2013 
China 
(Fruiting body) 
(cultivated) 
Hot water extraction; 
ethanolprecipitation; Sevag 
method; dialysis 
na na na na na In vivo 
SOD activity; 
GSH-Px activity; 
CAT activity; 
MDA levels 
200 mg/kg body weight increased the 
antioxidant activity of the enzymes and 
decreased the MDA levels in mice with 
exercise-induced oxidative stress 
Zhonghui et al., 
2013 
na 
(Mycelium) 
(cultivated) 
Ultrasonic assisted 
extraction; hydrolysis; Sevag 
method; ethanol 
precipitation; anion-exchange 
DEAE Sephadex A-50 
column; regenerated 
cellulose bag filter; dialysis 
 GC-MS- FID; 
FT/IR 
Heteroglucans 
(GLPI, GLPII, 
GLPIII, 
GLPIV) 
na GLPI- arabinose; 
rhamnose; xylose; 
mannose; glucose 
 
GLPII- arabinose; 
xylose; glucose 
 
GLPIII- arabinose; 
rhamnose; xylose; 
galactose; 
mannose; glucose 
 
GLPIV- 
arabinose; 
rhamnose; fucose; 
xylose; mannose; 
glucose 
 
 
 
na In vitro 
HO. scavenging 
activity; 
DPPH scavenging 
activity; 
Reducing power 
(RP); 
Fe2+chelating 
activity; 
ABTS scavenging 
activity; 
SOD-like activity 
HO. EC50: GLPI 1.25 mg/mL; GLPII 0.156 
mg/mL; GLPIII 0.156 mg/mL; GLPIV 
0.156 mg/mL 
 
DPPH EC50: GLPI 2.2 mg/mL; GLPII 1.25 
mg/mL; GLPIII 0.156 mg/mL; GLPIV 
0.156 mg/mL 
 
RP EC50: GLPI 9.00 mg/mL; GLPII 7.5 
mg/mL; GLPIII 5.00 mg/mL; GLPIV 3.00 
mg/mL 
 
Fe2+ EC50: GLPI - GLPIV ˃ 10.0 mg/mL;  
 
ABTS EC50 GLPI 7.5 mg/mL; GLPII ˃ 
10.0 mg/mL; GLPIII 2.00 mg/mL; GLPIV 
1.50 mg/mL 
 
SOD-like EC50: GLPI - GLPIV ˃ 10.0 
mg/mL 
Shi et al., 2013 
Taiwan Alkaline extraction; HPAEC; GC- LMG: β-1,3 Glucose 3.979 KDa In vitro 100 µg/mL increased the viability of cells Kao et al., 2012 
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(fruiting body) 
(na) 
hydrolysis; size-exclusion 
chromatography 
MS; NMR; 
MALDI-TOF 
MS 
Homoglucan MTT assay 
(RAW264.7 cells);  
ROS formation; 
nSMase and aSMase 
activities 
 
with H2O2-induced oxidative stress from 
40% to 80% and significantly reduced ROS 
formation 
 
nSMase inhibition: IC50 120  µg/mL; 
aSMase inhibition: IC50 100  µg/mL 
China 
(fruiting body) 
(na) 
Hot water extraction; D301R 
macroporous adsorption/ion 
exchange resin column; 
DEAE-Cellulose-32 column; 
gel filtration chromatography 
Size exclusion 
HPLC; 
methylation 
analysis; GC, 
GC-MS; EI-MS; 
IR spectra 
GLPL1: 
Homoglucan 
 
GLPL2: 
Heteroglucan 
β (1-3), (1-4) and 
(1-6) 
 
GLPL1: Glucose. 
 
GLPL2: Glucose; 
galactose, 
mannose 
GLPL1: 5.2 KDa; 
 
GLPL2: 15.4 KDa 
In vitro 
HO.scavenging 
activity; 
O2.-scavenging 
activity;  
Fe2+chelating 
activity;  
Reducing power 
(RP); 
H2O2 scavenging 
activity 
HO. EC50: GLPL1 0.63 mg/mL; GLPL2 2.50 
mg/mL 
 
O2.- EC50: GLPL1 2.12 mg/mL; GLPL2 10.0 
mg/mL 
 
Fe2+ EC50: GLPL1 6.0 mg/mL; GLPL2 ˃ 
10.0 mg/mL 
 
RP  EC50:  GLPL1-  GLPL2 ˃ 10.0 mg/mL 
 
H2O2 EC50: GLPL1 6.0 mg/mL; GLPL2  ˃ 
10.0 mg/mL 
Liu et al., 2010 
China 
(fruiting body) 
(cultivated) 
Hot water extraction; 
ethanolprecipitation; Sevag 
method; dialysis; 
precipitation with cetyl 
trimethyl ammonium 
hydroxide; DEAE cellulose 
column; anion exchange 
column of DEAE-Sepharose 
Fast Flow 
TLC Homopolysacch
aride 
na Mannose na In vivo 
SOD activity; 
CAT activity; 
GSH-Px activity; 
TAOC level; 
TBARS (MDA 
levels) 
300mg/kg body weight decreased MDA 
levels and increased SOD, CAT, GSH-Px 
activities and TAOC levels in rats with 
ovarian cancer 
YouGuo et al., 
2009 
China 
(fruiting body) 
(cultivated) 
Hot water extraction; 
ethanolprecipitation; Sevag 
method; dialysis; 
precipitation with cetyl 
trimethyl ammonium 
hydroxide; DEAE cellulose 
column; anion exchange 
column of DEAE-Sepharose 
Fast Flow. 
TLC Homopolysacch
aride 
na Mannose na In vitro 
O2.-scavenging 
activity;  
HO.scavenging 
activity; 
DPPH scavenging 
activity. 
 
In vivo  
SOD activity; 
CAT activity; 
GSH-Px activity 
O2.- EC50: 1.5 mg/mL 
 
HO. EC50: 2.2 mg/mL 
 
DPPH  EC50:  1.0 mg/mL 
 
 
 
300 mg/kg  body weight increased SOD, 
CAT and GSH-Px activities in rats with 
cervical carcinoma 
 
XiaoPing et al., 
2009 
China 
(fruiting body) 
(cultivated) 
Hot water extraction; 
ethanolprecipitation; Sevag 
method; dialysis 
na Heteroglucan β-  D- Rhamnose; D- 
xylose; D-
fructose; D- 
galactose; D- 
mannose; D- 
0.5848 KDa In vitro 
TBARS; 
LOOH; 
Protein carbonyls 
formation; 
60 mg/mL decreased  levels of TBARS, 
LOOH and protein carbonyls formation, 
and increased protein thiols formation and 
SOD, GSH-Px, CAT activities in 
mitochondria with  
Li et al., 2007 
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ABTS – 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); aSMase – acidic SMase; CAT – Catalase; DEAE – Diethylaminoethanol; 
DPPH – 2,2-diphenyl-1-picrylhydrazyl; EC50, IC50 – Concentration of polysaccharide providing 50% of antioxidant activity; EI – Electron 
ionization; FID – Flame ionization detector; FT-IR – Fourier transform infrared spectrophotometer; GC – Gas chromatography; GSH-Px –
Glutathione peroxidase; H2O2 – Hydrogen peroxide; HO. – Hydroxyl radical; HPAEC – High-performance anion-exchange chromatography; HP-
GPC – High-performance gel permeation chromatography; HPLC – High performance liquid chromatography; IR – Infrared; LOOH – Lipid 
hydroperoxides; MALDI-TOF – Matrix assisted laser desorption ionization-time of flight; MDA – Malondialdehyde; MS – Mass spectrometry; 
MTT – 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; NMR – Nuclear magnetic resonance; nSMase – Neutral SMase; O2.- 
– Superoxide radical; ORAC – Oxygen radical absorbance capacity; RAW 264.7 – Mouse leukaemic monocyte macrophage cell line; ROS – 
Reactive oxygen species; RP – Reducing power; SMase – Sphingomyelinase; SOD – Superoxide dismutase; TAOC – Total antioxidant capacity; 
TBARS – Thiobarbituric acid reactive substances; TLC – Thin layer chromatography.na –data not available.   
glucose Protein thiols 
formation; 
SOD activity; 
CAT activity; 
GSH-Px activity 
γ-irradiation induced oxidative stress 
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Table 2: Analytical procedures, chemical characterization and antitumor activity of polysaccharides isolated from Ganoderma species. 
Ganoderma 
species Origin 
Extraction/isolation 
procedure 
Identification 
technique 
Polysaccharide 
type 
Main glycosidic 
bonds 
Sugars 
composition 
Molecular 
weight 
Antitumor activity 
assays/ Dose 
Antitumor model 
used in the study 
Antitumor activity 
values 
References 
G. lucidum 
(fruiting body) 
Japan 
(cultivated) 
Hot water extraction; 
ethanol precipitation; 
Sevag method; DEAE-
cellulose column 
chromatography with 
sodium hydrogen 
carbonate 
PC; GLC; 
IR;13C NMR 
Branched 
heteroglucan 
(arabinoxyloglu
can) 
β-D-(1→3), β-D-
(1→6), and 
(1→4)-α- and -β- 
Glucose; 
xylose; 
arabinose 
40000 In vivo 
Tumorigenicity 
assay: calculation of 
the tumor inhibition 
ratio (%) in ICR 
mice 
5-20 × 10 (mg/Kg × 
day)  
Sarcoma 180 solid 
tumor 
42.0 – 98.5 % of 
inhibition ratio 
Miyazaki 
and  
Nishijima, 
1981 
G. lucidum 
(fruiting body) 
Japan 
(cultivated) 
First extraction with 
cold PBS (separation 
of the soluble and 
insoluble fractions). 
Hot water, and cold 
and hot 1M sodium 
hydroxide; treatment 
with cetyl pyridinium 
chloride (CPC) and 
glucoamylase; 
hydrolysis with acid 
 
GLC; PC; 
HPLC 
Water-soluble 
heteropolysacch
arides 
 Glucose; 
galactose; 
mannose; 
xylose; 
arabinose; 
fucose 
Na In vivo 
Tumorigenicity 
assay: calculation of 
the tumor inhibition 
ratio (%) in IRC-
JCL mice 
10 × 10 (mg/Kg × 
day) 
Sarcoma 180 solid 
tumor 
na Sone et al., 
1985 
Water-insoluble 
glucans 
(1→3)-β-D-
glucan with a few 
short 
(1→4)-linked 
glucosyl units 
Glucose Na 10.9 – 97.9 % of 
inhibition ratio 
G. lucidum 
(growing 
culture of 
mycelium) 
Japan 
(cultivated) 
Ethanol precipitations/ 
Toyopearl HW-65S 
column 
chromatography 
 
GLC; PC; 
HPLC 
Branched 
homoglucan 
(1→3)-β-D-
glucan 
Glucose Na In vivo 
Tumorigenicity 
assay: calculation of 
the tumor inhibition 
ratio (%) in IRC-
JCL mice 
10 × 10 (mg/Kg × 
day) 
Sarcoma 180 solid 
tumor 
91.6 % of inhibition 
ratio   
Sone et al., 
1985 
G. lucidum 
(fruiting body) 
na Hot water followed by 
ethanol precipitation 
Na Branched 
homoglucan 
(1→3)-β-D-
glucan with 
(1→6)-β-D 
branches 
 
Glucose GLPO < 
12.000 
 GLP I > 
12.000 
In vivo 
Tumorigenicity 
assay  (BALB/c 
mice; Details not 
available) 
 
Sarcoma 180 solid 
tumor 
Induced a cascade of 
immunomodulatory 
cytokines 
Ooi et al., 
2002  
G. tsugae 
(mycelium) 
China 
(cultivated) 
Immersion  in 0.2 M 
sodium phosphate 
buffer (pH 7.0); Sevag 
method; H2O2; 
dialysis; isolation with 
phosphate buffer, 
IR; GC; 
13C NMR 
Heteroglucans (1→3)-β-D-
glucans and 
(1→4)-α-D-
glucans; and 
(1→6)-branched 
(1→3)-β-D-
Rhamnose; 
fucose; 
xylose; 
mannose; 
galactose; 
glucose; N-
GTM3- 
465×10-4 
GTM4-
468×10-4 
GTM5- 
176×10-4 
In vivo 
Tumorigenicity 
assay: calculation of 
the tumor inhibition 
ratio (%) and   
enhancement of 
Sarcoma 180 solid 
tumor 
12.9– 55.06 % of 
inhibition ratio 
11.5 – 39.1 %  
enhancement of 
body weight ratio 
Peng et al., 
2005 
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BALB/c mice – albino laboratory-bred strain of the house mouse from which a number of common sub-strains are derived; DEAE – 
Diethylaminoethyl; GC – Gas chromatography; GLC – Gas liquid chromatography; HPGFC – High performance gel filtration chromatography; 
HP-GPC – High performance gel permeation chromatography; HPLC – High performance liquid chromatography; HPLC-FID – High 
performance liquid chromatography coupled to a flame ionization detector; ICR mice – Imprinting control regions, strain of albino mice 
distilled water and 0.5 
M sodium hydroxide 
glucan acetylglucosa
mine 
GTM6- 
161×10-4 
body weight ratio 
(%) in BALB/c mice 
5-37.5 × 10 (mg/Kg 
× day) 
G. lucidum 
(fruiting body) 
China 
(cultivated) 
Extraction with 95% 
ethanol; ultrasonic-aid 
extraction (UAE); 
DEAE cellulose-52 
chromatography and 
Sephadex G-100 size-
exclusion 
chromatography 
Spectrophotome
try (UV); 
HPGFC; 
IR 
Heteropolysacc
haride 
na Glucose; 
galactose; 
mannose; 
rhamnose; 
fucose 
GP-1- 
1.926 KDa 
GP-2- 1086 
KDa 
In vitro 
MTT assay 
5, 25, 50 µg/mL 
Human breast 
cancer cell line 
(MDA-MB-231) 
0.347–0.352 (OD 
values at 490 nm) 
corresponding to 
inhibition ratios of 
0.50 – 6.72 %; 
Immunomodulatory 
activity (increasing 
macrophage cells 
proliferation) 
Zhao et al., 
2010 
G. lucidum 
(mycelium) 
China 
(cultivated) 
Hot water; ethanol 
precipitation; Sevag 
method; dialysis 
IR; UV; 
NMR 
Heteropolysacc
haride 
α-D-Glc(1→6), α-
D-Glc, α-D-Man 
(rhamnose and 
arabinose residues 
in the side chain) 
Rhamnose; 
arabinose; 
mannose; 
glucose; 
galactose 
3.500 KDa In vitro and in vivo 
MTT assay; Cell 
cycle assay by Flow 
cytometry; 
Tumorigenicity 
assay:  calculation 
of the tumor 
inhibition ratio (%) 
in ICR mice 
500, 1000, 2000  
µg/mL (for the in 
vitro assays) 
0.5 and 2.0 × 8 
(mg/Kg × day) (for 
the in vivo assays) 
 
Human 
hepatocarcinoma 
cell line (HepG2) 
Tumour xenografts 
in ICR mice 
0 – ≈ 35 % of 
inhibition rate (in 
vitro) 
31.39–55.02 % of 
inhibition rate (in 
vivo); 
Apoptosis enhanced 
by supplemental 
dose of the 
intracellular 
polysaccharides 
 
Liu et al., 
2012;  
Zhang et 
al., 2012 
G. lucidum 
(fruiting body) 
 
 
China 
(cultivated) 
Pretreatment with 
ethanol; Sevag 
method; Ultrasonic 
cell 
disruption; 
ultrafiltration 
HP-GPC; 
HPLC-FID; GC 
Heteroglucans na Mannose; 
Rhamnose; 
glucose; 
galactose 
GLP- na; 
GLP1-
˃10KDa; 
GLP2- 8-10 
KDa; 
GLP3- 2.5-
8 KDa; 
GLP4- ˂ 
2.5 KDa 
In vitro 
MTT assay 
0.05, 0.25 and 1 
mg/mL 
Adrenal gland from 
rat -PC12 cell line 
≈12.5 - ≈52.5 % of 
inhibition activity 
Ma et al., 
2013 
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originating in Switzerland; IRC-JCL – Another strain of albino mice originating in Switzerland; IR – Infrared spectroscopy; MTT – 3-[4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide; NMR – Nuclear magnetic resonance spectroscopy; OD – Optical Density; PBS – 
Phosphate buffered saline; PC – Paper chromatography; UV – Ultraviolet. na –data not available.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   57	  
Table 3: Analytical procedures, chemical characterization and antimicrobial activity of polysaccharides isolated from Ganoderma lucidum. 
 
DEAE – Diethylaminoethanol. na –data not available.   
*Branched homoglucan; (1→3)-β-D-glucan with (1→6)-β-D branches; composed by D-mannose, D-galactose, D-glucose, L-arabinose, L-
fucose, D-fructose and L-rhamnose.  
 
 
 
 
 
Ganoderma species Origin Extraction/isolation 
procedure 
Antimicrobial activity assay Microorganisms used Type of assay Reference 
G. lucidum 
 
Poland 
(cultivated) 
Hot water followed by 
ethanol precipitation/ 
DEAE-cellulose column 
chromatography 
 
Microdilution method 
Staphylococcus epidermidis, S.aureus,  
Bacillus subtilis, Micrococcus luteus Escherichia coli 
Klebsiella pneumonia, Pseudomonas aeruginosa 
Proteus mirabilis 
In vitro Skalicka-Woźniak et al., 2012 
G.lucidum China 
(wild) 
Hot water Agar diffusion  method Erwinia carotovora,Penicillium digitatum, 
Botrytis cinerea, Bacillus cereus 
Bacillus subtilis, Escherichia coli 
Aspergillus niger, Rhizopus nigricans 
In vitro Bai et al., 2008 
G. applanatum India 
(wild) 
na Cup diffusion method Acitenobacter aerogenes 
Acrobacter aerogenes Arthrobacter citreus,  
Bacillus brevis, B.subtilis Corynebacterium insidiosum  
Escherichia coli, Proteus vulgaris 
Clostridium pasteurianum, Micrococcus roseus 
Mycobacterium phlei, Sarcina lutea 
Staphylococcus aureus 
In vitro Bhattacharyya et al., 2006 
G.formosanum 
(mycelia)* 
 
Taiwan 
(cultivated) 
 
Ethanol extraction to 
allow the precipitation 
dissolution in boiled 
Tris/HCl buffer, the 
sample 
was fractionated on a 
Sepharose CL-6B gel 
filtration 
column 
na Listeria monocytogenes In vivo 
on mice; 
enhanced microbial 
killing, which 
is mostly mediated by 
monocytes/macrophages 
and neutrophils 
Wang et al., 2011a 
G.  lucidum 
(mycelia) 
India 
(cultivated) 
na Well diffusion method 
 
Escherichiacoli, Staphylococcus aureus 
Proteus sp, Bacillus subtilis, Pseudomonas aeroginosa 
Klebsiella sp ,Bacillus cereus 
In vitro Mahendran et al., 2013 
	   58	  
Table 4: Polysaccharides isolated from Ganoderma species without reported bioactivity. 
 
Ganoderma 
species 
Origin Extraction/isolation 
procedure 
Identification 
technique 
Polysaccharide type Main glycosidic bonds Sugars 
composition 
Molecular 
weight 
References 
G. japonicum 
(fruiting body) 
Japan 
(wild) 
Hot dichloromethane and hot 
methanol;  
Hot water; Dialysis; gel 
filtration on Sepharose CL-
4B 
GLC-MS; 1H-
NMR; IR; PC  
Alkali-soluble glucan β -(1→3)-linked D-
glucopyranosyl residues 
with side-chains of single, 
β  - (1→6)-linked D-
glucopyranosyl groups 
Glucose; 
laminarabiose 
82000 Ukai et al., 
1982 
G. lucidum 
(fruiting body)  
China 
(cultivated) 
PBS; Ethanol precipitations; 
1N NaOH 
 
13C-NMR;1H-
NMR; IR 
Water insoluble 
glucans 
(1→3)- α -D-glucans Glucose GL4-1 - 
1.95x105;  
GL4-2 – 
1.33x10-4 
Chen et al., 
1998 
G. lucidum 
(spores) 
na 
(cultivated) 
Hot water followed by 
ethanol precipitation 
13C-NMR; GC; 
GC-MS; IR 
Water soluble 
polysaccharide 
(1→3)-linked-Glc; 
(1→6)-linked-Gal; 
(1→4)-linked-Gal; 
(1→6)-linked-Glc 
Glucose; 
galactose 
1.41x104 Zhao et al., 
2005  
G. tlucidum 
(germinating 
spores) 
na 
(cultivated) 
Deproteinization by Sevag 
method and frozen-thaw 
method, fractionated by 
ultrafiltration and gel 
chromatography on CL-6B 
column. 
GC; HPLC; IR; 
NMR  
Heteropolysaccharide Na Glucose; 
galactose 
1.41x105 Zhang et al., 
2006 
G. resinaceum 
(fruiting body) 
Brazil 
(wild) 
Chloroform-methanol; Hot 
water; dialysis;  Freeze-
thawing; ultrafiltration 
GC-MS; GPC;  
NMR  
Water soluble glucan (1→3)-linked  β -glucan Glucose; 
mannose; 
galactose; 
xylose 
2.6x104 Amaral et al., 
2008 
G. lucidum 
(fruiting body) 
China 
(wild) 
Hot water followed by 
ethanol precipitation; 
ultrafiltration 
FT-IR;HPAPC;  
NMR  
Water soluble 
polysaccharide 
1,6-disubstituted-α-
galactopyranosyl, 1,2,6-
trisubstituted- 
α-galactopyranosyl, 1,3-
disubstituted-β -
glucopyranosyl and 1,4,6-
trisubstituted-β -
glucopyranosyl 
residues  
Fucose; 
glucose; 
galactose 
7000Da Ye et al., 2009 
G. lucidum 
(fruiting body) 
China 
(cultivated) 
Utrasonic/microwave 
assisted extraction 
FT-IR; GC-MS; 
HPSEC; NMR 
Water soluble neutral 
polysaccharide 
Backbone: 1,4-
disubstituted- β -
glucoseopyranose and 
Glucose; 
galactose 
2.5x106kDa Huang et al., 
2011 
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1,4,6-trisubstituted- 
β –glucoseopyranosyl; 
Branched chains: 1,6-
disubstituted- β -
glucopyranosyl and 1,4- 
disubstituted- β–
galactoseopyranosyl 
G. lucidum 
(fruiting body) 
China 
(cultivated) 
Ethyl-acetate; Sevag method; 
Dialysis 
FT-IR; GC-MS;  
NMR  
Water soluble 
Heteropolysaccharides 
(1→4)-galactan 
heteropolysaccharide; 
(1→3)-glucan; 
1,4,6-glucan, (1→3)-
galactan, (1→6)-galactan, 
(1→4)-grabinan, 
(1→3)-mannan, and/or 
(1→4)-xylan linkages 
glucose, 
galactose, 
mannose, 
arabinose 
GL-I – 6.1x104;  
GL-V – 
10.3x104 
Wang et al., 
2011 
G. lucidum  
(spores) 
China 
(cultivated) 
Hot-water extraction, graded 
ethanol precipitation, anion-
exchange chromatography 
 
GPL; HPGPC; 
NMR 
Water soluble glucan Backbone: 1,6-linked β -
D-Glcp; 
Side chain: 1,4-linked 
Glcp residues 
Glucose 103 kDa Dong et al., 
2012 
 
FT-IR – Fourier transform infrared spectrophotometer; GC- Gas chromatography; GC-MS – Gas chromatography coupled to mass spectrometry; 
GLC-MS – Gas liquid chromatography coupled to mass spectrometry; GPC – Gel permeation chromatography; HPGPC – High performance gel 
permeation chromatography; HPLC – High performance liquid chromatography; HPSEC – High pressure size exclusion chromatography; IR – 
Infrared spectroscopy; NMR – Nuclear magnetic resonance spectroscopy; PC – Paper chromatography; na –data not available.   
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